CHClaudio Maierovitch Pessanha Henriques

Claudio Maierovitch Pessanha Henriques

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Claudio Maierovitch Pessanha Henriques has a total of 106 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    V Plan Director para el Desarrollo de la Epidemiología en Brasil (2025–2029)

    by Tânia Maria de Araújo, Enirtes Caetano Prates Melo, Claudia Leite de Moraes, Laio Magno, Ana Paula Muraro, Maria de Jesus Mendes da Fonseca, Alberto Novaes Ramos Júnior, Luana Giatti Gonçalves, Margareth Guimarães Lima, Ligia Regina de Oliveira, et al.

    Resumen está disponible en el texto completo

  • Open Access

    Fifth Strategic Plan for the Development of Epidemiology in Brazil (2025–2029)

    by Tânia Maria de Araújo, Enirtes Caetano Prates Melo, Claudia Leite de Moraes, Laio Magno, Ana Paula Muraro, Maria de Jesus Mendes da Fonseca, Alberto Novaes Ramos Júnior, Luana Giatti Gonçalves, Margareth Guimarães Lima, Ligia Regina de Oliveira, et al.

    The Brazilian Association of Collective Health (Abrasco) has played a leading role in consolidating collective health in Brazil since its foundation. After 19 years, Abrasco's Epidemiology Committee resumed its planning with the development of the Fifth Strategic Plan for the Development of Epidemiology in Brazil (2025–2029). This plan emerged in a challenging context marked by social inequalities, scientific denialism, the COVID-19 pandemic, the climate crisis, and disinvestment in public policies, reinforcing the need to update Brazilian epidemiology. The plan's development occurred in multiple stages, including online surveys, debates, and in-person workshops. Workshop I (Brasília, 2023) identified priority challenges, and Workshop II (Rio de Janeiro, 2024) defined strategies to address them. The construction process was guided by the qualified participation of epidemiologists from all regions of the country and was based on principles of plurality, diversity, gender equity, and race/ethnicity. The plan highlights epidemiology across three thematic areas: education, research, and health policies, programs, and services. The Strategic Plan Working Group of the Epidemiology Committee, supported by the Secretariat of Health and Environment Surveillance of the Ministry of Health, led the process. This supplement of the Brazilian Journal of Epidemiology presents the Fifth Strategic Plan for the Development of Epidemiology in Brazil (2025–2029), contributions to the discussion of some central topics, and a deepening of strategic and operational dimensions. The Fifth Strategic Plan for the Development of Epidemiology in Brazil (2025–2029) presents a collective vision for the future, aiming to strengthen epidemiology as a central discipline within the field of collective health. It reaffirms its commitment to equity, social justice, and the consolidation of the Sistema Único de Saúde in Brazil.


  • Open Access

    Perfil de venda de antimicrobianos no Brasil de 2014 a 2021: análise dos registros do Sistema Nacional de Gerenciamento de Produtos Controlados

    by Jakeline Ribeiro Barbosa, Giovanny Vinícius Araújo de França, Aurélio Matos Andrade, Beatriz Torres Araújo, Cláudio Maierovitch Pessanha Henriques, Mariana Pastorello Verotti

    RESUMO Objetivo: Analisar o perfil de dispensação de antimicrobianos no Brasil durante o período de 2014 a 2021 com base nos registros do Sistema Nacional de Gerenciamento de Produtos Controlados (SNGPC) da Agência Nacional de Vigilância Sanitária (Anvisa). Métodos: Foi realizado um estudo ecológico descritivo, de série temporal, utilizando dados de farmácias e drogarias privadas, sobre a venda de medicamentos antimicrobianos. Foram incluídos medicamentos vendidos de janeiro de 2014 a novembro de 2021, com análise das variáveis: mês, ano, município, estado, princípio ativo, conselho de classe do prescritor, sexo e idade do paciente. Resultados: No período do estudo, foram registradas 532.518.866 vendas de medicamentos de controle especial no SNGPC, sendo 66,8% de antimicrobianos. Observou-se um aumento nas vendas até 2019, com queda em 2020, período da pandemia de COVID-19, e novo aumento em 2021. As regiões Sudeste e Nordeste concentraram as maiores vendas, com a Sudeste liderando. As vendas foram mais altas entre mulheres, especialmente na faixa etária de 30 a 44,9 anos, com um aumento de vendas em pacientes com 60 anos ou mais. Os antimicrobianos mais vendidos foram amoxicilina, azitromicina, ciprofloxacino e cefalexina. Conclusão: O estudo revela diferenças de consumo por região, gênero e idade, e destaca a importância de intervenções educativas para o uso responsável de antimicrobianos. Aponta ainda que a suspensão do registro obrigatório de dados no SNGPC pode comprometer o monitoramento necessário para combater a resistência bacteriana e melhorar a saúde pública no Brasil.


  • Open Access

    Antimicrobial sales profile in Brazil from 2014 to 2021: analysis of records from the National System of Controlled Products Management

    by Jakeline Ribeiro Barbosa, Giovanny Vinícius Araújo de França, Aurélio Matos Andrade, Beatriz Torres Araújo, Cláudio Maierovitch Pessanha Henriques, Mariana Pastorello Verotti

    Objective: To analyze the antimicrobial dispensing profile in Brazil from 2014 to 2021 based on records from the Brazilian National System of Controlled Products Management (SNGPC) of the Brazilian Health Regulatory Agency (Anvisa). Methods: A descriptive, time-series ecological study was carried out using data from private pharmacies and drugstores on the sale of antimicrobial drugs. Drugs sold from January 2014 to November 2021 were included, with analysis of the variables of month, year, municipality, state, active ingredient, prescriber’s professional council, and patient’s sex and age. Results: During the study period, 532,518,866 sales of special control drugs were recorded in SNGPC, 66.8% of which were antimicrobials. There was an increase in sales up to 2019, with a decrease in 2020, during the COVID-19 pandemic, and a new increase in 2021. The Southeast and Northeast regions concentrated the highest sales, with the Southeast leading. Sales were higher among women, especially in the 30 to 44.9 age group, with an increase in sales among patients aged 60 or older. The best-selling antimicrobials were amoxicillin, azithromycin, ciprofloxacin and cephalexin. Conclusion: The study reveals differences in consumption by region, sex, and age, and it highlights the importance of educational interventions for the responsible use of antimicrobials. It also points out that the suspension of mandatory data registration in SNGPC may compromise the monitoring necessary to combat bacterial resistance and improve public health in Brazil.


  • Open Access

    Review of: "Post-Pandemic Reflections from Sub-Saharan Africa: What We Know Now That We Wish We Knew Then"

    by Claudio Henriques

    That is an important article that brings important issues to better the comprehension of COVID-19 epidemics in the context of Sub-Saharan Africa. The conclusions, in my opinion, are really relevant to feed the discussions about preparedness and resp...

  • Open Access

    Challenges and lessons from the COVID-19 pandemic for Health Surveillance in Brazil: reflections on technologies, models, and system organization

    by Claudio Maierovitch Pessanha Henriques, Noely Fabiana Oliveira de Moura, Priscila Bochi de Souza

    The term "health surveillance" encompasses a wide range of activities, including the monitoring and observation of harms and diseases. We will investigate the most well-known aspect of health surveillance, namely the monitoring of communicable diseases. To illustrate our discussion, we will use the pandemic caused by the SARS-CoV-2 virus as a case study. As the text progresses, the focus shifts to an examination of technologies, models, and the structure of the system. The most severe epidemic of our era, classified as a pandemic due to its global impact, has compelled us to reflect on a multitude of areas of knowledge. The resulting suffering should preclude any association with positive images, despite the opportunity to learn and, in some instances, observe the capacity of humans to act in solidarity. It is often observed that few things are as didactic as tragedies and mistakes. Therefore, it is worth investigating them carefully to extract the necessary feedback to correct the course of action in health. In this text, we will discuss the conditions that led health surveillance in Brazil to fail miserably in its mission in the face of the emergency triggered by the 2019 new coronavirus disease. We will also present points that deserve attention in a restructuring of the health surveillance system.


  • Open Access

    Desafios e lições da pandemia de COVID-19 para a Vigilância em Saúde no Brasil: reflexões sobre tecnologias, modelos e organização do sistema

    by Claudio Maierovitch Pessanha Henriques, Noely Fabiana Oliveira de Moura, Priscila Bochi de Souza

    RESUMO A vigilância em saúde, como vigilância de agravos e doenças, tem um escopo bastante amplo. Discutimos aqui a face mais conhecida, que é a vigilância de doenças transmissíveis, e assumimos como mote a pandemia causada pelo vírus SARS-CoV-2. No desenvolvimento do texto, a abordagem se amplia para uma reflexão sobre tecnologias, modelo e organização do sistema. A mais grave epidemia de nossa época, classificada como pandemia por atingir simultaneamente todo o planeta, tem obrigado a reflexões que envolvem múltiplos campos do conhecimento. O sofrimento decorrente deve inibir a tentação de associá-la a qualquer imagem positiva, ainda que tenha havido oportunidade para aprender e, em algumas circunstâncias, testemunhar a capacidade humana de agir solidariamente. Poucas coisas são tão didáticas como tragédias e erros. Cabe explorá-los cuidadosamente e extrair a necessária retroalimentação para corrigir rumos da atuação em saúde. Neste texto, tratamos das condições que levaram a vigilância em saúde no Brasil a falhar fragorosamente em sua missão perante a emergência desencadeada pela doença do novo coronavírus 2019 e levantamos pontos que merecem atenção em uma reestruturação do sistema de vigilância em saúde.


  • Open Access

    Fortalecer as atividades de informação e vigilância epidemiológica é essencial e urgente para reduzir a força de transmissão do SARS-CoV-2

    by Maria Glória Teixeira, Ligia Regina Franco Sansigolo Kerr, Ricardo Arraes de Alencar Ximenes, Rosa Lívia Freitas de Almeida, Maria Yury Ichihara, Maria de Fátima Militão de Albuquerque, Estela M L Aquino, Guilherme Loureiro Werneck, Eduardo Hage Carmo, Roberto Andrade Medronho, et al.

    SciELO Preprints Collection is an integral part of SciELO, an international cooperation program aiming at the development of open access scientific communication covering all areas of knowledge. It operates as a collection of non-peer-reviewed manuscripts within the SciELO Network of national and thematic collection of journals.


  • Open Access

    Crises dentro da crise: respostas, incertezas e desencontros no combate à pandemia da Covid-19 no Brasil

    by Cláudio Maierovitch Pessanha Henriques, Wagner Vasconcelos

    RESUMO O autores descrevem a organização, no âmbito do Sistema Único de Saúde, do arcabouço para resposta a situações de emergência em saúde pública, especificamente a preparação para a entrada da pandemia causada por Sars-CoV-2 no Brasil. São discutidas as contradições da ação do Estado em meio à grave crise político-institucional. A resistência ao conhecimento científico num ambiente de conflito político e crescimento do autoritarismo é representada na disputa de narrativas que sustentam propostas antagônicas para enfrentar a crise. Informações falsas (fake-news) alimentam a cisão e confundem-se com a própria decisão do Governo Federal de dificultar o acesso a informações. A negação da gravidade da situação e a inexistência de um plano nacional de ação são mais exuberantes no momento em que o país se torna um dos epicentros da pandemia de Covid-19.


  • Open Access

    The global scientific research response to the public health emergency of Zika virus infection

    by Juliane Fonseca De Oliveira, Julia Moreira Pescarini, Moreno De Souza Rodrigues, Bethania De Araujo Almeida, Claudio Maierovitch Pessanha Henriques, Fabio Castro Gouveia, Elaine Teixeira Rabello, Gustavo Correa Matta, Mauricio L Barreto, Ricardo Barros Sampaio

    Science studies have been a field of research for different knowledge areas, and they have been successfully used to analyse the construction of scientific knowledge, practice and dissemination. In this study, we aimed to verify how the Zika epidemic has moulded the scientific articles published worldwide by analysing international collaborations and the knowledge landscape through time, as well as research topics and country involvement. We searched the Web of Science (WoS), Scopus and PubMed for studies published up to 31st December 2018 on Zika using the search terms “zika”, “zkv” or “zikv”. We analysed the scientific production regarding which countries have published the most, on which topics, as well as country level collaboration. We performed a scientometric analysis of research on Zika focusing on knowledge mapping and the scientific research path over time and space. We found two well defined research areas divided into three subtopics accounting for six clusters. With regard to country analysis, the USA and Brazil were the countries with the highest numbers of publications on Zika. China entered as a new player focusing on specific research areas. When we took into consideration the epidemics and reported cases, Brazil and France were the leading research countries on related topics. As for international collaboration, the USA followed by England and France stand out as the main hubs. The research areas most published included public health-related topics from 2015 until the very beginning of 2016, followed by an increase in topics related to the clinical aspects of the disease in 2016 and the emergence of laboratory research in 2017/2018. Mapping the response to Zika, a public health emergency, demonstrated a clear pattern of the participation of countries in the scientific advances. The pattern of knowledge production found in this study represented varying country perspectives, research capacity and interests based first on their level of exposure to the epidemic and second on their financial positions regarding science.